Robert L. Camp - Publications, H-index & Citations

Robert L. Camp

Yale University

62H指数

253论文数

1.6W被引数

收录论文 73

发表时间

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

CLINICAL CANCER RESEARCH

IF10.2

2018-01-02

OAAI

Jilaveanu, Lucia B.; Puligandla, Maneka; Weiss, Sarah A.; Wang, Xin Victoria; Zito, Christopher; Flaherty, Keith T.; Boeke, Marta; Neumeister, Veronique; Camp, Robert L.; Adeniran, Adebowale; Pins, Michael; Manola, Judith; DiPaola, Robert S.; Haas, Naomi B.; Kluger, Harriet M.

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma

CANCER CELL INTERNATIONAL

IF6

2014-01-14

OAAI

Aziz, Saadia A.; Sznol, Joshua A.; Albiges, Laurence; Zito, Christopher; Jilaveanu, Lucia B.; Camp, Robert L.; Escudier, Bernard; Kluger, Harriet M.

c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma

ANNALS OF ONCOLOGY

IF65.4

2013-02-01

158

OAAI

Gibney, G. T.; Aziz, S. A.; Camp, R. L.; Conrad, P.; Schwartz, B. E.; Chen, C. R.; Kelly, W. K.; Kluger, H. M.

Vascularity of primary and metastatic renal cell carcinoma specimens 原发性和转移性肾细胞癌标本的血管分布

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2013-01-14

OAAI

Aziz, Saadia A.; Sznol, Joshua; Adeniran, Adebowale; Colberg, John W.; Camp, Robert L.; Kluger, Harriet M.

Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

BREAST CANCER RESEARCH

IF5.6

2012-09-12

OAAI

Agarwal, Seema; Gertler, Frank B.; Balsamo, Michele; Condeelis, John S.; Camp, Robert L.; Xue, Xiaonan; Lin, Juan; Rohan, Thomas E.; Rimm, David L.

Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome

CLINICAL CANCER RESEARCH

IF10.2

2012-01-16

285

OAAI

Lazova, Rossitza; Camp, Robert L.; Klump, Vincent; Siddiqui, Summar F.; Amaravadi, Ravi K.; Pawelek, John M.

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

BREAST CANCER RESEARCH

IF5.6

2011-11-02

OAAI

Baquero, Maria T.; Lostritto, Karen; Gustavson, Mark D.; Bassi, Kimberly A.; Appia, Franck; Camp, Robert L.; Molinaro, Annette M.; Harris, Lyndsay N.; Rimm, David L.

Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2011-08-17

PREAI

Chagpar, Anees B.; Camp, Robert L.; Rimm, David L.

Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables

LABORATORY INVESTIGATION

IF4.2

2011-08-01

OAAI

Bai, Yalai; Tolles, Juliana; Cheng, Huan; Siddiqui, Summar; Gopinath, Arun; Pectasides, Eirini; Camp, Robert L.; Rimm, David L.; Molinaro, Annette M.

LC3B-positive autophagosomes are a common feature of solid tumors and associated with proliferation, metastasis and poor outcome

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Lazova, Rossitza; Camp, Robert; Siddiqui, Summar; Klump, Vincent; Pawelek, John M.

In vitro studies of dasatinib, its targets and predictors of sensitivity

PIGMENT CELL & MELANOMA RESEARCH

IF2.6

2011-03-10

OAAI

Jilaveanu, Lucia B.; Zito, Christopher R.; Aziz, Saadia A.; Chakraborty, Ashok; Davies, Michael A.; Camp, Robert L.; Rimm, David L.; Dudek, Arkadiusz; Sznol, Mario; Kluger, Harriet M.

Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma

CLINICAL CANCER RESEARCH

IF10.2

2010-12-16

OAAI

Aziz, Saadia A.; Jilaveanu, Lucia B.; Zito, Christopher; Camp, Robert L.; Rimm, David L.; Conrad, Patricia; Kluger, Harriet M.

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

BREAST CANCER RESEARCH

IF5.6

2010-09-01

OAAI

Parisi, Fabio; Gonzalez, Ana M.; Nadler, Yasmine; Camp, Robert L.; Rimm, David L.; Kluger, Harriet M.; Kluger, Yuval

PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2010-06-04

102

OAAI

VanHouten, Joshua; Sullivan, Catherine; Bazinet, Caroline; Ryoo, Tom; Camp, Robert; Rimm, David L.; Chung, Gina; Wysolmerski, John

Dual targeting of PI3K and mTOR results in synergistic growth inhibition in NSCLC cells

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Chao, Herta H.; Zito, Christopher; Jilaveanu, Lucia; Anagnostou, Valsamo; Rimm, David; Bepler, Gerold; Camp, Robert; Kluger, Harriet M.

Autophagy in malignant melanoma and breast carcinoma

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Lazova, Rossitza; Klump, Vincent; Siddiqui, Summar; Camp, Robert; Pawelek, John

High expression of the microtubule destabilizing protein stathmin is prognostic for worse outcome in breast cancer

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Baquero, Maria; Hanna, Jason; Agarwal, Seema; Killiam, Elizabeth; Camp, Robert L.; Rimm, David L.

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer

ANNALS OF ONCOLOGY

IF65.4

2010-03-01

OAAI

Nadler, Y.; Gonzalez, A. M.; Camp, R. L.; Rimm, D. L.; Kluger, H. M.; Kluger, Y.

C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas

CLINICAL CANCER RESEARCH

IF10.2

2009-09-14

OAAI

Jilaveanu, Lucia B.; Zito, Christopher R.; Aziz, Saadia A.; Conrad, Patricia J.; Schmitz, John C.; Sznol, Mario; Camp, Robert L.; Rimm, David L.; Kluger, Harriet M.

Quantitative Multiplexed Analysis of ErbB Family Coexpression for Primary Breast Cancer Prognosis in a Large Retrospective Cohort

CANCER

IF5.1

2009-05-20

OAAI

Giltnane, Jennifer M.; Moeder, Christopher B.; Camp, Robert L.; Rimm, David L.

研究方向